205 related articles for article (PubMed ID: 26996594)
21. Phase I-II clinical trial of Californium-252. Treatment of stage IB carcinoma of the cervix.
Maruyama Y; VanNagell JR; Yoneda J; Donaldson E; Gallion H; Rowley K; Kryscio R; Beach JL
Cancer; 1987 Apr; 59(8):1500-5. PubMed ID: 3028603
[TBL] [Abstract][Full Text] [Related]
22. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
Toita T; Kato S; Niibe Y; Ohno T; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Tokumaru S; Yamauchi C; Suzuki O; Sakurai H; Numasaki H; Teshima T; Oguchi M; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e49-56. PubMed ID: 21470794
[TBL] [Abstract][Full Text] [Related]
23. [Intracavitary radiotherapy with Cf-252 for uterine cervical carcinomas].
Fukuda K
Gan No Rinsho; 1984 Feb; 30(2):145-51. PubMed ID: 6608595
[TBL] [Abstract][Full Text] [Related]
24. Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix.
Nakano T; Kato S; Ohno T; Tsujii H; Sato S; Fukuhisa K; Arai T
Cancer; 2005 Jan; 103(1):92-101. PubMed ID: 15540233
[TBL] [Abstract][Full Text] [Related]
25. High-dose-rate vs. low-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix: Systematic review and meta-analysis.
Lee KK; Lee JY; Nam JM; Kim CB; Park KR
Brachytherapy; 2015; 14(4):449-57. PubMed ID: 25906951
[TBL] [Abstract][Full Text] [Related]
26. High dose rate cobalt-60 afterloading intracavitary therapy for cervical carcinoma in Srinagarind hospital - analysis of survival.
Pesee M; Krusun S; Padoongcharoen P
Asian Pac J Cancer Prev; 2010; 11(6):1469-71. PubMed ID: 21338182
[TBL] [Abstract][Full Text] [Related]
27. Feasibility and acute toxicity of Concurrent Chemoradiotherapy (CCRT) with high-dose rate intracavitary brachytherapy (HDR-ICBT) and 40-mg/m2 weekly cisplatin for Japanese patients with cervical cancer: results of a Multi-Institutional Phase 2 Study (JGOG1066).
Toita T; Kitagawa R; Hamano T; Umayahara K; Hirashima Y; Aoki Y; Oguchi M; Mikami M; Takizawa K;
Int J Gynecol Cancer; 2012 Oct; 22(8):1420-6. PubMed ID: 22932262
[TBL] [Abstract][Full Text] [Related]
28. Long-term effectiveness and safety of image-based, transperineal combined intracavitary and interstitial brachytherapy in treatment of locally advanced cervical cancer.
Tiwari R; Narayanan GS; Narayanan S; Suresh Kumar P
Brachytherapy; 2020; 19(1):73-80. PubMed ID: 31813739
[TBL] [Abstract][Full Text] [Related]
29. High dose rate cobalt-60 afterloading intracavitary therapy of uterine cervical carcinomas in Srinagarind hospital - analysis of complications.
Pesee M; Krusun S; Padoongcharoen P
Asian Pac J Cancer Prev; 2010; 11(2):491-4. PubMed ID: 20843138
[TBL] [Abstract][Full Text] [Related]
30. [The preliminary report of cervical cancer treated with californium-252 neutron after loading intracavitary radiotherapy].
Luo G; Zheng C; Shan J
Zhonghua Fu Chan Ke Za Zhi; 2001 Dec; 36(12):742-4. PubMed ID: 16136896
[TBL] [Abstract][Full Text] [Related]
31. High dose-rate intracavitary brachytherapy for cervical carcinomas with lower vaginal infiltration.
Kazumoto T; Kato S; Tabushi K; Kutsutani-Nakamura Y; Mizuno H; Takahashi M; Shiromizu K; Saito Y
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1157-66. PubMed ID: 17459604
[TBL] [Abstract][Full Text] [Related]
32. Treatment of stage IIIB cervical cancer with Californium-252 fast-neutron brachytherapy and external photon therapy.
Gallion HH; Maruyama Y; van Nagell JR; Donaldson ES; Rowley KC; Yoneda J; Beach JL; Powell DE; Kryscio RJ
Cancer; 1987 May; 59(10):1709-12. PubMed ID: 3828944
[TBL] [Abstract][Full Text] [Related]
33. Neutron brachytherapy is better than conventional radiotherapy in advanced cervical cancer.
Maruyama Y; Kryscio R; van Nagell JR; Yoneda J; Donaldson E; Hanson M; Beach JL; Feola JM; Martin A; Parker C
Lancet; 1985 May; 1(8438):1120-2. PubMed ID: 2860334
[TBL] [Abstract][Full Text] [Related]
34. Treatment outcome of medium-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix: comparison with low-dose-rate intracavitary brachytherapy.
Kaneyasu Y; Kita M; Okawa T; Maebayashi K; Kohno M; Sonoda T; Hirabayashi H; Nagata Y; Mitsuhashi N
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):137-45. PubMed ID: 22285665
[TBL] [Abstract][Full Text] [Related]
35. Radiotherapy for uterine cervical cancer: results of the 1995-1997 patterns of care process survey in Japan.
Toita T; Nakamura K; Uno T; Kodaira T; Shinoda A; Ogawa K; Mitsuhashi N; Maebayashi K; Kawaguchi A; Inoue T; Teshima T
Jpn J Clin Oncol; 2005 Mar; 35(3):139-48. PubMed ID: 15741304
[TBL] [Abstract][Full Text] [Related]
36. External Beam Radiation Therapy and Brachytherapy for Cervical Cancer: The Experience of the National Centre for Radiotherapy in Accra, Ghana.
Vulpe H; Asamoah FA; Maganti M; Vanderpuye V; Fyles A; Yarney J
Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1246-1253. PubMed ID: 29395628
[TBL] [Abstract][Full Text] [Related]
37. High versus low dose rate intracavitary irradiation for adenocarcinoma of the uterine cervix.
Kim WC; Kim GE; Suh CO; Loh JJ
Jpn J Clin Oncol; 2001 Sep; 31(9):432-7. PubMed ID: 11689597
[TBL] [Abstract][Full Text] [Related]
38. A review of californium-252 neutron brachytherapy for cervical cancer.
Maruyama Y; van Nagell JR; Yoneda J; Donaldson ES; Gallion HH; Powell D; Kryscio RJ
Cancer; 1991 Sep; 68(6):1189-97. PubMed ID: 1873769
[TBL] [Abstract][Full Text] [Related]
39. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.
Lee SW; Suh CO; Chung EJ; Kim GE
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1338-44. PubMed ID: 11955747
[TBL] [Abstract][Full Text] [Related]
40. High dose rate Cobalt-60 after loading intracavitary therapy of the uterine cervical carcinoma in Srinagarind Hospital, analysis of residual disease.
Pesee M; Krusun S; Padoongcharoen P
Asian Pac J Cancer Prev; 2012; 13(9):4835-7. PubMed ID: 23167428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
